$PNNX Pennexx Acquired BitGift which is an open loop
Top 10 Most Recent News Articles
Scania's Q3 Results: A Resilient Yet Uneven Ride
Scania Steadies the Ship in Q3 with Robust Growth Sailing through a patchy global market, Swedish powerhouse Scania's latest quarterly figures reflect a mixed bag of results. Their performance in this third quarter of 2026 stood strong, despite some wobbles. The company showed resilience in sales and profitability, with numbers telling a tale that's a bit like a truck...
Continue Reading
Uwharrie Capital's 2026 Q3 Shows Steady Growth
Uwharrie Capital's Financial Dance Well, don't dust off the neon ticker tape quite yet but Uwharrie Capital Corp (OTCQX:UWHR) gave us a reason to nod approvingly over our espresso this quarter. From a scrappy hometown operation to a regional bank showing its mettle, the numbers they've laid down ain't half bad. Assets Climb a Billion-Dollar Ladder First thing that jumps...
Continue Reading
Infinite Electronics Reveals Cutting-Edge Connectivity at Electronica
Infinite Electronics Makes Waves at Electronica 2026 Let’s get down to brass tacks: Infinite Electronics is setting up one heck of a show at the electronica 2026 in Munich from November 10–13. They're not just there to give out free pens—these guys mean business with connectivity products that cover everything from drones to industrial automation. A Showcase of...
Continue Reading
Peptide Therapy Rules Change: Gameday Ups the Ante
Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...
Continue Reading
Wendy's Faces Takeover Bid Amid Strategic Focus Shift
Behind the Unsolicited Offer Folks, it looks like Wendy's (NASDAQ:WEN) got itself mixed up in some high-stakes shenanigans. An unsolicited, non-binding proposal slammed into them, courtesy of the Investor Group led by Trian Partners, Flynn Group LP, BlueFive Capital, and Sixth Street Partners, itching to scoop up every last piece of Wendy’s stock they ain't already...
Continue Reading
Probiotics in Animal Feed: Market Reaches $8.76B by 2031
Let's cut straight to the chase: the probiotics in animal feed market is steaming ahead, set to grow from a respectable $5.82 billion in 2026 to a hearty $8.76 billion by 2031. We're talking about a solid CAGR of 8.5% here. Now that's the kind of growth trajectory that gets even the most jaded traders sitting up and taking notice. Big Numbers in Livestock Nutrition...
Continue Reading
Honeywell Aerospace Posts Solid Q3, Raises Guidance
Honeywell Aerospace Surprises with Strong Third Quarter In a world where numbers are often as slippery as a greased pig, Honeywell Aerospace (NASDAQ:HONA) has managed to pin down a surprisingly robust third quarter. Let’s break it down: they’ve claimed sales of a cool $4.6 billion, reflecting a 2% bump both in reported and organic revenue from the previous year, and...
Continue Reading
Firehawk Defense Secures $150M, Valuation Hits $1.4B
Firehawk Defense Lands Major Funding Think about it—Firehawk Defense, a gutsy Dallas-based new-kid-on-the-block, just snagged a whopping $150 million in fresh funding. The news? Their valuation's now sitting pretty at $1.4 billion. Not peanuts, by any means. For a company in the artillery game, that's a blast of an announcement. They're predicting they'll become the big...
Continue Reading
FirstEnergy's New Tech to Bolster Pennsylvania Grid
Electricity Demand Spurs Grid Innovation The winds of change are blowing across Pennsylvania's power grid. FirstEnergy Transmission's (NYSE:FE) subsidiary, Keystone Appalachian Transmission Company (KATCo), is diving into a significant federally funded project to reinforce grid reliability. With electricity demand on an upward trajectory, Pennsylvania and beyond need...
Continue Reading
Tech's Role in Shaping Tomorrow's Classroom: 2026 Insights
Schools at a Crossroads: Career Skills Take Center Stage The data's out, and boy, is it telling. Project Tomorrow's 23rd Annual Speak Up Report brings a bushel of insights—some you'd expect, some that'll knock your socks off. With over 95,000 K-12 folks raising their voices, this is no small potatoes look into modern education's heartbeat. Parents Crying Out for...
Continue ReadingTop 5 Most Recently Viewed Articles
Innovative AI Assistant by ClickBid Revolutionizes Fundraising
ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...
Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars
Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...
Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference
Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...
Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge
Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...
Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone
MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...
Continue Reading